Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Mar 2010

Tabori Uri, Baskin Berivan, Shago Mary, Alon Noa, Taylor Michael D, Ray Peter N, Bouffet Eric, Malkin David, Hawkins Cynthia

Abstract excerpt

PURPOSE: Medulloblastoma is the prototype of treatment success in modern pediatric neuro-oncology. Unfortunately, 20% to 30% of tumors recur despite maximal resection and multimodal therapy. Multiple biologic prognostic markers have been investigated to predict recurrences, but controversy remain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genes, p53
Share to Medulloblastoma
Share to Multivariate Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ontario

Share to Receptor, ErbB-2

Share to Sensitivity and Specificity

Share to Survival Analysis

Share to Treatment Failure

Source

Identifiers

PMID: 20142599
DOI: 10.1200/JCO.2009.23.5952

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20142599-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations.PMID 20142599Read ↗

p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease.Semantic proximity Read ↗

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.Semantic proximity Read ↗

Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndromeSemantic proximity Read ↗

The evolution of medulloblastoma therapy to personalized medicineSemantic proximity Read ↗

Expression of p53 and prognosis in children with malignant gliomas.Semantic proximity Read ↗

p53 and Meduloblastoma.Semantic proximity Read ↗

Overexpressed TP73 induces apoptosis in medulloblastomaSemantic proximity Read ↗

Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort studySemantic proximity Read ↗

Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.Semantic proximity Read ↗

Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).Semantic proximity Read ↗

Clinically applicable 39 genes targeted mutational analysis predicts recurrence in pediatric medulloblastoma: a monocenter cohort studySemantic proximity Read ↗

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.